DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Sean McCarthy will join a roundtable discussion of “How to Transform your Technology into a Sustainable Marketable Product” at the San Jose BioCenter.
News | 03. 22. 2007
